CVE-2023-0959

CVE-2023-0959 is a medium-severity vulnerability in Imaworldhealth Bhima with a CVSS 3.x base score of 6.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-269.

Key facts

Description

Bhima version 1.27.0 allows a remote attacker to update the privileges of any account registered in the application via a malicious link sent to an administrator. This is possible because the application is vulnerable to CSRF.

Frequently asked questions

What is CVE-2023-0959?
Bhima version 1.27.0 allows a remote attacker to update the privileges of any account registered in the application via a malicious link sent to an administrator. This is possible because the application is vulnerable to CSRF.
How severe is CVE-2023-0959?
CVE-2023-0959 has a CVSS 3.x base score of 6.5, rated medium severity. It is exploitable over network with low attack complexity, requires no privileges and user interaction. Impact on confidentiality is none, integrity high, and availability none.
Is CVE-2023-0959 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (50th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-0959?
CVE-2023-0959 affects Imaworldhealth Bhima. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2023-0959?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2023-0959 published?
CVE-2023-0959 was published on 2023-04-05 and last updated on 2026-06-17.

References

Affected products (1)

More vulnerabilities in Imaworldhealth Bhima

All CVEs affecting Imaworldhealth Bhima →

Other CWE-269 (Improper Privilege Management) vulnerabilities

Browse all CWE-269 (Improper Privilege Management) vulnerabilities →